InspireMD, Inc.
NSPRNasdaqCIK 1433607HealthcareFiscal year ends Dec 31
Reports and events: 529 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-08-0516:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030265 |
| 2024-07-0107:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-025714 |
| 2024-06-1316:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-023685 |
| 2024-06-1208:10 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-023546 |
| 2024-05-3116:52 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-022222 |
| 2024-05-2809:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-021463 |
| 2024-05-1407:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019080 |
| 2024-05-1316:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018889 |
| 2024-04-1816:15 ET | DEF 14A | Proxy statementPeriod 2024-04-18 | 0001493152-24-015191 |
| 2024-04-0209:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-012648 |
| 2024-03-2607:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-011233 |
| 2024-03-0607:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-008941 |
| 2024-03-0516:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-008850 |
| 2024-01-3108:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-004411 |
| 2023-12-2007:22 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-045512 |
| 2023-11-2707:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-042709 |
| 2023-11-0616:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-039519 |
| 2023-11-0607:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-039434 |
| 2023-11-0114:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-038979 |
| 2023-10-1208:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-036981 |
| 2023-10-0616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-036502 |
| 2023-09-1316:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-23-032486 |
| 2023-08-3108:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-030726 |
| 2023-08-0807:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-027101 |
| 2023-08-0717:25 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-027060 |
| 2023-07-2816:30 ET | DEF 14A | Proxy statementPeriod 2023-07-28 | 0001493152-23-025891 |
| 2023-07-2116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-025237 |
| 2023-06-2608:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-022352 |
| 2023-06-1616:15 ET | SC 13D | Ownership report, active investor | 0001493152-23-021668 |
| 2023-05-2309:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-018659 |
| 2023-05-1609:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-017646 |
| 2023-05-1516:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-017367 |
| 2023-05-1516:06 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-017317 |
| 2023-03-3008:02 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-009598 |
| 2023-03-3007:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-009596 |
| 2023-03-2008:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-008192 |
| 2022-11-0807:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-030876 |
| 2022-11-0716:05 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-030818 |
| 2022-09-0116:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-22-024842 |
| 2022-08-1116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-022086 |
| 2022-08-0816:06 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-021613 |
| 2022-07-0516:30 ET | DEF 14A | Proxy statementPeriod 2022-07-05 | 0001493152-22-018544 |
| 2022-06-0317:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-015872 |
| 2022-05-2016:15 ET | 8-K | 8.01 Other events | 0001493152-22-014604 |
| 2022-05-1007:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-012618 |
| 2022-05-0916:30 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-012567 |
| 2022-03-0809:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-22-006266 |
| 2022-03-0716:25 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-006180 |
| 2022-02-2809:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-005566 |
| 2022-01-1016:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-000829 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:46 ET. Listed shows no prices and gives no investment advice.